Shenzhen Lifotronic Biotechnology Co., Ltd. announced that it will raise CNY 97,020,000 in an equity round of funding on October 24, 2023. The transaction will include participation from returning investor, Shenzhen Lifotronic Technology Co., Ltd. for CNY 33,000,000, individual investors Liu Xiancheng for CNY 15,000,000, Hu Minglong for CNY 3,000,000, Ceng Ying for CNY 2,000,000 and 5 ESOP?s for CNY 44,020,000. The company's registered capital will increase from CNY 3,000,000 to CNY 100,020,000 post transaction.

The transaction has been approved in the 26th Meeting of the Company?s 2nd Directorate and the 24th Meeting of the 2nd Supervisory Board.